Kallikrein 6 Induces E-Cadherin Shedding and Promotes Cell Proliferation, Migration, and Invasion
- 1 September 2007
- journal article
- research article
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 67 (17), 8198-8206
- https://doi.org/10.1158/0008-5472.can-07-0607
Abstract
Recently, we described phorbol ester–induced expression of the brain and skin serine proteinase Bssp/kallikrein 6 (Klk6), the mouse orthologue of human KLK6, in mouse back skin and in advanced tumor stages of a well-established multistage tumor model. Here, we show KLK6 up-regulation in squamous skin tumors of human patients and in tumors of other epithelial tissues. Ectopic Klk6 expression in mouse keratinocyte cell lines induces a spindle-like morphology associated with accelerated proliferation, migration, and invasion capacity. We found reduced E-cadherin protein levels in the cell membrane and nuclear translocation of β-catenin in Klk6-expressing mouse keratinocytes and human HEK293 cells transfected with a KLK6 expression plasmid. Additionally, HEK293 cells exhibited induced T-cell factor–dependent transcription and impaired cell-cell adhesion in the presence of KLK6, which was accompanied by induced E-cadherin ectodomain shedding. Interestingly, tissue inhibitor of metalloproteinase (TIMP)-1 and TIMP-3 interfere with KLK6-induced E-cadherin ectodomain shedding and rescue the cell-cell adhesion defect in vitro, suggesting the involvement of matrix metalloproteinase and/or a disintegrin and metalloproteinase (ADAM) proteolytic activity. In line with this assumption, we found increased levels of the mature 62-kDa ADAM10 proteinase in cells expressing ectopic KLK6 compared with mock controls. Finally, enhanced epidermal keratinocyte proliferation and migration in concert with decreased E-cadherin protein levels are confirmed in an in vivo Klk6 transgenic mouse model. [Cancer Res 2007;67(17):8198–206]Keywords
Other Versions
This publication has 40 references indexed in Scilit:
- Proteinase-activated Receptors, Targets for Kallikrein SignalingPublished by Elsevier BV ,2006
- Increased Soluble E-Cadherin in Melanoma PatientsSkin Pharmacology and Physiology, 2006
- Identification of novel tumour-associated genes differentially expressed in the process of squamous cell cancer developmentOncogene, 2005
- Human tissue kallikrein gene family: applications in cancerCancer Letters, 2005
- Clinical Significance of Human Kallikrein Gene 6 Messenger RNA Expression in Colorectal CancerClinical Cancer Research, 2005
- Human Kallikrein 6 Degrades Extracellular Matrix Proteins and May Enhance the Metastatic Potential of Tumour CellsTumor Biology, 2004
- Keratinocyte-Specific Onset of Serine Protease BSSP Expression in Experimental CarcinogenesisJournal of Investigative Dermatology, 2001
- AP-1 and Cbfa/Runt Physically Interact and Regulate Parathyroid Hormone-dependent MMP13 Expression in Osteoblasts through a New Osteoblast-specific Element 2/AP-1 Composite ElementJournal of Biological Chemistry, 2001
- The Hallmarks of CancerCell, 2000
- The conversion stage of skin carcinogenesisCarcinogenesis: Integrative Cancer Research, 1990